Journal article
Novel Anti-Neuroinflammatory Properties of a Thiosemicarbazone–Pyridylhydrazone Copper(II) Complex
XY Choo, LE McInnes, A Grubman, JM Wasielewska, I Belaya, E Burrows, H Quek, JC Martín, S Loppi, A Sorvari, D Rait, A Powell, C Duncan, JR Liddell, H Tanila, JM Polo, T Malm, KM Kanninen, PS Donnelly, AR White
International Journal of Molecular Sciences | Published : 2022
Abstract
Neuroinflammation has a major role in several brain disorders including Alzheimer’s disease (AD), yet at present there are no effective anti-neuroinflammatory therapeutics available. Copper(II) complexes of bis(thiosemicarbazones) (CuII(gtsm) and CuII(atsm)) have broad therapeutic actions in preclinical models of neurodegeneration, with CuII(atsm) demonstrating beneficial outcomes on neuroinflammatory markers in vitro and in vivo. These findings suggest that copper(II) complexes could be harnessed as a new approach to modulate immune function in neurodegenerative diseases. In this study, we examined the anti-neuroinflammatory action of several low-molecular-weight, charge-neutral and lipophi..
View full abstractRelated Projects (3)
Grants
Awarded by University of Queensland
Funding Acknowledgements
This research was funded by the National Health and Medical Research Council of Australia (NHMRC) GNT0628946, and GNT1118452, and the Australian Research Council, (ARC) DP150100649, DP160100288, DP200100178 and the APC was funded by The University of Queensland.